Other languages Twist Bioscience Corporation

Equities

TWST

US90184D1000

Market Closed - Nasdaq Other stock markets 04:00:03 2024-05-31 pm EDT			5-day change	1st Jan Change
41.88 ^USD	+2.57%		-0.83%	+13.62%

May. 22	Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine	CI
May. 13	Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-Throughput Screening Applications	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Twist Bioscience to Present at Upcoming Investor Conferences	May. 23
Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine	May. 22
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications	May. 13
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-Throughput Screening Applications	May. 13
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(4)	May. 09
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	May. 08
Sector Update: Health Care Stocks Mixed Late Afternoon	May. 03
Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 03
Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised	May. 03
Twist Bioscience : Fiscal 2024 2Q Financial Results	May. 02
Twist Bioscience: Fiscal Q2 Earnings Snapshot	May. 02
Transcript : Twist Bioscience Corporation, Q2 2024 Earnings Call, May 02, 2024	May. 02
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Posts Q2 Revenue $75.3M, vs. Street Est of $70.8M	May. 02
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results	May. 02
Twist Bioscience Corporation Revises Earnings Guidance for the Fiscal Year 2024	May. 02
Twist Bioscience Corporation Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2024	May. 02
Twist Bioscience Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 02
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024	Apr. 18
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	Mar. 28
Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	Mar. 28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Twist Bioscience Corporation

Equities

TWST

US90184D1000

Other languages

Filters